30 April 2017
News and Views
Links and Services
The latest issue of Gut investigates the temporal evolution of antidrug antibodies in patients with IBD treated with infliximab.
Dr Shomron Ben-Horin and colleagues from Israel characterized the temporal evolu
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors